ENTX
Entera Bio Ltd.
NASDAQHealthcareBiotechnologyIL
Rating:C
Company Profile
CEO
Miranda J. Toledano
IPO Date
2018-06-28
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
IL
Entera Bio Ltd.
CEO
Miranda J. Toledano
IPO Date
2018-06-28
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
IL
| 58,394 |
| $0.00 |
| 8 May 2026 | Burshtein Gregory | Chief of R&D | A-Award | Acquired | 87,591 | $0.00 |
| 11 Mar 2026 | Germano Geno J | director | P-Purchase | Acquired | 20,000 | $1.30 |
| 9 Mar 2026 | Ellis Sean | director | P-Purchase | Acquired | 10,000 | $1.23 |
| 11 Feb 2026 | Taitel Haya | director | P-Purchase | Acquired | 7,500 | $1.48 |
| 11 Feb 2026 | Germano Geno J | director | P-Purchase | Acquired | 20,000 | $1.49 |
| 11 Feb 2026 | Ellis Sean | director | P-Purchase | Acquired | 18,000 | $1.24 |
| 9 Feb 2026 | Germano Geno J | director: | Disposed | 0 | $0.00 |
| 2 Jan 2026 | OSTROV GERALD M | director | A-Award | Acquired | 28,721 | $0.00 |